Interaction of statin therapy to angiotensin ii receptor type 1 blockers in erectile dysfunction patients. effect on endothelial function and aortic stiffness
The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy
Physiologically-based pharmacokinetic (PBPK) model predicted versus observed effect of Child Pugh mild and moderate hepatic impairment on betrixaban pharmacokinetics
Speaker:
Doctor J. Leeds (South San Francisco, US)